<DOC>
	<DOCNO>NCT01752699</DOCNO>
	<brief_summary>Neuropathic pain common condition affect 40 70 % general population . Post-herpetic neuralgia condition almost complex require multi modal treatment . Aim : This pilot proof-of-principle study design evaluate use low-dose methadone post-herpetic neuralgia patient remain refractory first second line treatment post-herpetic neuralgia ( PHN ) indication association opioid agent current drug regimen .</brief_summary>
	<brief_title>Methadone Post-Herpetic Neuralgia Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Patients chronic ( &gt; 6 month ) symptomatic PHN visual analogical scale &gt; 40/100mm use first second line drug ( tricyclic antidepressant , venlafaxine gabapentinoids ) Do n't full criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>neuropathic pain ,</keyword>
	<keyword>post-herpetic neuralgia ,</keyword>
	<keyword>methadone ,</keyword>
</DOC>